Tool
Stock screener
Filter the 3753 large-cap US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
28 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↓ |
|---|---|---|---|---|---|---|---|---|
| CareDxCDNA | 63.04 | -1.18% | $3.26B | 30.31 | -- | +326.2% | B 99 | |
| IlluminaILMN | 267.76 | -2.11% | $40.43B | 49.96 | -- | +173.8% | B 97 | |
| Guardant HealthGH | 168.33 | -1.38% | $22.59B | -- | -- | +157.7% | B 97 | |
| NateraNTRA | 395.56 | -1.27% | $57.02B | -- | -- | +129.9% | B 96 | |
| GrailGRAL | 132.90 | -3.19% | $5.94B | -- | -- | +82.6% | B 95 | |
| Adaptive BiotechnologiesADPT | 26.28 | -2.30% | $4.19B | -- | -- | +69.0% | B 91 | |
| NeoGenomicsNEO | 15.97 | -3.24% | $2.05B | -- | -- | +74.2% | B 90 | |
| RevvityRVTY | 153.60 | +0.20% | $17.14B | 73.85 | 0.18% | +67.8% | B 88 | |
| FreenomeFRNM | 16.03 | -2.02% | $1.72B | -- | -- | +51.2% | B 83 | |
| Castle BiosciencesCSTL | 33.00 | -1.08% | $1.01B | -- | -- | +39.9% | B 74 | |
| WatersWAT | 435.99 | -0.10% | $42.84B | 110.38 | -- | +33.1% | B 74 | |
| Quest DiagnosticsDGX | 227.06 | -0.58% | $25.06B | 24.10 | 1.08% | +27.2% | B 70 | |
| Thermo Fisher ScientificTMO | 662.06 | +0.83% | $244.79B | 35.63 | 0.27% | +23.8% | C 64 | |
| Agilent TechnologiesA | 169.09 | -0.14% | $47.67B | 33.35 | 0.60% | +20.8% | C 62 | |
| VeracyteVCYT | 43.16 | -3.34% | $3.47B | 30.83 | -- | +23.0% | C 61 | |
| Mettler-Toledo InternationalMTD | 1,533.48 | +0.03% | $30.73B | 34.57 | -- | +15.4% | C 56 | |
| Labcorp HoldingsLH | 311.97 | +0.08% | $25.30B | 25.80 | 0.92% | +13.6% | C 56 | |
| MedpaceMEDP | 604.25 | +0.22% | $16.87B | 35.50 | -- | +13.8% | C 55 | |
| Sotera Health CompanySHC | 17.90 | -1.92% | $5.11B | 31.40 | -- | +11.9% | C 52 | |
| Opko HealthOPK | 1.39 | -4.79% | $1.04B | -- | -- | -10.3% | D 51 | |
| Fulgent GeneticsFLGT | 20.57 | -0.05% | $565.99M | -- | -- | -9.9% | D 46 | |
| DanaherDHR | 218.49 | +1.34% | $153.60B | 38.81 | 0.66% | +7.2% | C 44 | |
| Qiagen NVQGEN | 44.79 | -1.88% | $9.25B | 22.77 | 0.78% | -5.4% | D 34 | |
| RadNetRDNT | 68.61 | -2.38% | $5.40B | -- | -- | -9.8% | D 25 | |
| Icon PLCICLR | 164.08 | +1.48% | $12.66B | 252.43 | -- | -12.0% | D 24 | |
| IDEXX Laboratories IncIDXX | 506.67 | -1.70% | $39.92B | 35.61 | -- | -19.6% | D 19 | |
| GeneDx HoldingsWGS | 68.53 | -4.18% | $2.04B | -- | -- | -44.1% | E 5 | |
| BillionToOneBLLN | 95.75 | -4.19% | $4.52B | 135.05 | -- | -- | C 0 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.